BI 1815368, BI 1815368 Placebo, BI 1815368
1485-0018
Phase 2 small_molecule active
Quick answer
BI 1815368, BI 1815368 Placebo, BI 1815368 for Centre-involved diabetic macular edema is a Phase 2 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Centre-involved diabetic macular edema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active